Medicamen Biotech Ltd (MEDICAMEQ)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 342.30
% Change: -1.10% (Prev Close: 346.10)

Volume: 37,084
% Change: 68.96% (Prev Volume: 21,948)

Delivery: 23,027
Delivery % : 62.09
% Change: 31.89% (Prev Delivery: 17,459)

Turnover: 131 Lacs
% Change: 70.29% (Prev Turnover: 77)

πŸ’Ή EOD Valuation

P/E Ratio: 46.57
P/B Ratio: 2.05
Market Cap: 466 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: MEDICAMEQ
Market Cap: 468 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 630.00
52 Week Low: 341.20

All-Time High: 1225.00 Rs.
All-Time Low: 4.75 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-7.93% | -17.34% | -27.17% | -18.14% | -31.53%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 40.46%

Change (3Y | 1Y): -3.14% | -2.70%

Pledged %: 0.00%

FII Holding

FII Holding: 0.00%

Change (3Y | 1Y): -0.35% | -0.12%

DII Holding

DII Holding: 0.64%

Change (3Y | 1Y): 0.64% | -0.05%

Public Holding: 58.83%

🏦 Financial Strength

Debt to Equity: 0.16
Debt: 33.25 Rs. Cr.

Book Value: 167.35 Rs.
Current Ratio: 2.11
Interest Coverage: 3.90
Free Cash Flow: -9.26 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: -9.91%

Sales Growth Qtr (YOY | QoQ):
-0.02% | 45.36%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
5.31% | 12.08% | -9.91%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 28.28%

Profit Growth Qtr (YOY | QoQ):
59.26% | -13.51%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-11.81% | -21.86% | 28.28%

EPS Rs.

EPS (TTM): 7.35 Rs.

EPS Qtr (Last Year | Latest):
1.06 Rs. | 1.59 Rs.

EPS Annual (Last Annual | Annual March):
8.60 Rs. | 5.59 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-12.51% | -22.89%

Net Profit Rs. Cr.

Net Profit (TTM): 7.28 Rs. Cr.

Net Profit (Annual - March): 6.56 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
0.80| 1.85 | 1.60

EBITDA Rs. Cr.

EBITDA (Quarter): 5.08 Rs. Cr.
EBITDA (Previous Yr Ql): 4.04 Rs. Cr.

EBITDA (Annual - March): 20.11 Rs. Cr.
EBITDA (Previous Annual): 25.84 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
-1.30% | -7.98%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 9.24%

OPM Qtr (Previous | Current):
-5.44% | 10.71%

OPM Annual (5 Yrs | Last Yr | March):
14.84% | 13.11% | 8.53%

Return on Equity %

ROE: 3.39%

ROE (5 Yrs | 3 Yrs | Last Yr):
7.08% | 5.67% | 5.46%

Return on Capital Employed %

ROCE: 5.39%

ROCE (5 Yrs | 3 Yrs | Last Yr):
9.80% | 8.01% | 8.20%

Return on Assets %

ROA (TTM): 2.22%

ROA (5 Yrs | 3 Yrs | Last Yr):
4.99% | 3.79% | 3.31%

PEG Ratio: -2.26
Dividend Yield: 0.29%

PE 3 Yrs: 64.94
PE 5 Yrs: 60.00

Dividend Yield: 0.29%

πŸ‘₯ Company

Medicamen Biotech Ltd

MEDICAMEQ

Promoter Holding: %